La mitad de los pacientes asintomáticos con aterosclerosis subclínica precoz carecen de factores de riesgo cardiovascular tradicionales, como el tabaquismo, la hipertensión o la dislipemia, y muchos pacientes que presentan un síndrome coronario agudo no tienen niveles elevados de colesterol LDL, pero sí muestran inflamación aumentada.
¿Es la inflamación un factor de riesgo aún infravalorado? Lucía Matute pregunta a los cardiólogos Clara Bonanad, Ana López Suárez y Enrique Santas por este proceso, que tanto en su forma crónica como aguda juega un papel clave en la fisiopatología del síndrome coronario agudo, lo que ha suscitado un interés creciente por intervenciones antiinflamatorias como posibles estrategias terapéuticas.
- Inflammation in acute myocardial infarction: the good, the bad and the ugly. European Heart Journal (2024) 45, 89–103
- Repair of the Infarcted Heart: Cellular Effectors, Molecular Mechanisms and Therapeutic Opportunities. Circ Res. 2024 Jun 7;134(12):1718-1751. doi: 10.1161/CIRCRESAHA.124.323658
- Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease. Circ Res. 2020 Apr 24;126(9):1260-1280. doi: 10.1161/CIRCRESAHA.120.315937.
- Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials. The Lancet, Volume 401, Issue 10384, 1293 - 1301
- Inflammation and Cholesterol as Predictors of Cardiovascular Events Among 13 970 Contemporary High-Risk Patients With Statin Intolerance. Circulation. 2024 Jan 2;149(1):28-35.
- Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women. N Engl J Med 2024;391:2087-2097
- High-sensitivity C-reactive protein and risk of clinical outcomes in patients with acute heart failure. Sci Rep. 2024 Sep 17;14(1):21672
- Perivascular adipose tissue as a source of therapeutic targets and clinical biomarkers: A clinical consensus statement from the European Society of Cardiology Working Group on Coronary Pathophysiology and Micro-circulation, European Heart Journal, Volume 44, Issue 38, 7 October 2023, Pages 3827–3844, https://doi.org/10.1093/eurheartj/ehad484
- Advances in Clinical Imaging of Vascular Inflammation: A State-of-the-Art Review. JACC: BASIC TO TRANSLATIONAL SCIENCE VOL. 9, NO. 5, 2024 MAY 2024: 710–732
- Inflammatory risk and cardiovascular events in patients without obstructive coronary artery disease: the ORFAN multicentre, longitudinal cohort study. Lancet. 2024 Jun 15;403(10444):2606-2618. doi: 10.1016/S0140-6736(24)00596-8.
- Noninvasive Coronary Atherosclerotic Plaque Imaging. J Am Coll Cardiol Img. 2023 Dec, 16 (12) 1608–1622
- Actualización del posicionamiento sobre obesidad y enfermedad cardiovascular y renal de las Asociaciones de Cardiología Preventiva, Cardiología Clínica e Insuficiencia Cardiaca de la SEC. REC CardioClinics. 2024;59(3):212-224
- Prognostic Usefulness of Serial C-Reactive Protein Measurements in ST-Elevation Acute Myocardial Infarction. American Journal of Cardiology, Volume 111, Issue 1, 26 – 30
- Preprocedural C-Reactive Protein Predicts Outcomes after Primary Percutaneous Coronary Intervention in Patients with ST-elevation Myocardial Infarction a systematic meta-analysis. Sci Rep 7, 41530 (2017). https://doi.org/10.1038/srep41530
- Anti-inflammatory therapies in myocardial infarction: failures, hopes and challenges. British J Pharmacology 2018
